FindMyKOL
Clinical trialNCT02547805CompletedPhase 2Interventional

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

SponsorAllena PharmaceuticalsEnrollment66Dietary HyperoxaluriaHyperoxaluriaKidney StonesNephrolithiasisSecondary Hyperoxaluria
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients with secondary hyperoxaluria and kidney stones.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinica Arizona

    Pheonix, Arizona, United States

  • Urological Associates of Southern Arizona, Pc

    Tuscon, Arizona, United States

  • Applied Research Center of Arkansas, Inc.

    Little Rock, Arkansas, United States

  • South Florida Medical Research, Llc

    Aventura, Florida, United States

  • Atlantic Urological Associates

    Daytona Beach, Florida, United States

  • Clinical Research Center of Florida

    Pompano Beach, Florida, United States

  • Idaho Urological Institute

    Meridian, Idaho, United States

  • Iu Health Physicians Urology

    Indianapolis, Indiana, United States

  • Regional Urology, Llc

    Shreveport, Louisiana, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Mayo Clinic Department of Medicine Clinical Trials Unit

    Rochester, Minnesota, United States

  • Delaware Valley Urology, Llc

    Voorhees Township, New Jersey, United States

  • Premier Medical Group of the Hudson Valley

    Poughkeepsie, New York, United States

  • Associated Urologists of North Carolina

    Raleigh, North Carolina, United States

  • Coastal Urology

    Wilmington, North Carolina, United States

  • Tristate Urologic Services Psc Inc. Dba the Urology Group

    Cincinnati, OH, Ohio, United States

  • Clinical Research Solutions, Llc

    Middleburg Heights, Ohio, United States

  • Omega Medical Research

    Warwick, Rhode Island, United States

  • Carolina Urologic Research Center

    Myrtle Beach, South Carolina, United States

  • Urology Clinics of North Texas Pllc

    Dallas, Texas, United States

  • Urology of Virginia

    Virginia Beach, Virginia, United States

  • Integrity Medical Research

    Mountlake Terrace, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ALLN-177Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
31 Jan 2017
Completion
31 Jan 2017
Last update posted
19 Jan 2017
Registered enrollment
66
Registry id
NCT02547805

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.